Neil Shneider, MD, PhD, Claire Tow Associate Professor of Neurology, talks about the new approved tofersen (Qalsody), the first drug developed for patients with a rare form of ALS
Dr. Andrew Lassman, John Harris Professor of Neurology, is the new director of the Irving Institute’s Network Capacity, national collaborative hub for trials, informatics, communication & education
A new study done by Dr. Jennifer Manly, professor of neuropsychology, and colleagues, found that the quality of the high school you attend may have an impact on cognition later in life
Mitchell Elkind, MD, MS, MPhil, professor of neurology and epidemiology, commented on a newly developed brain-computer interface that can read a person’s thoughts & translate them into full sentences
Miguel Arce Rentería, PhD, assistant professor of neuropsychology, commented on a study that found that people who were bilingual in their youth tended to score higher on memory tests later in life
Olajide Williams MD, MS, professor & chief of staff of neurology, received the 2023 ACTS Addressing Health Equity Through Partnership & Innovation Award for his transformative community-engaged work
Hiral Shah, MD, assistant professor of neurology at CUMC, along with colleagues, and patients support group created a book for Black patients & their families written by the true experts: themselves
Richard Mayeux, MD, chair of the Department of Neurology at CUMC and colleagues are investigating a set of blood tests that may help correctly diagnose Alzheimer disease in low-resource environments
Dr. Jinsy Andrews, associate professor of neurology at CUIMC, commented on the newly approved oral drug to treat amyotrophic lateral sclerosis (ALS), a nervous system disease that weakens muscles
Olajide Williams MD, MS, Professor and Chief of Staff of Neurology, participated in the “Hip Hop Health: Mind Over Music” panel hosted by Men’s Health.